Advanced Infusion Pumps are designed to monitor Patient Safety and avert Frequent Dosage Errors
Infusion pumps are one of the most widely medical devices used for faster drug administration in patients to give them quick relief. However, dosage errors, which can be user-initiated or due to the failure of infusion pump parts, remain the highest errors noted in infusion pump management. To avoid dosage errors some advanced infusions have been designed by various manufacturers. Some infusion pumps are designed for specialized purposes. For example, enteral infusion pumps are used to deliver liquid nutrients and medications to a patient’s digestive tract. Patient controlled analgesic pumps are infusion pumps used to deliver pain medication, which is equipped with a feature that allows patients to self-administer a controlled amount of medication, as needed. These infusion pumps are used mostly at home. As per the U.S. FDA, “a "smart pump" is equipped with safety features, such as user-alerts that activate when there is a risk of an adverse drug interaction, or when the user sets the pump's parameters outside of the specified safety limits. These advanced infusion pumps help in reducing dosage errors and maintaining patient safety. Advanced safety features in infusion pumps are aiding wider adoption among healthcare institutions and patients and thus, fuelling the infusion pump market’s revenue growth.
Increase in Reimbursement for Home Care Infusion Therapy under Medicare is expected to boost the Demand for Infusion Pumps
It is clearly noted that Part B and Part D of the U.S. Medicare covers some or all components of home infusion, depending on the circumstances. Reimbursement value increases for private payers if infusion therapy is done at home rather than at a hospital as associated charges are less. This is expected to promote revenue growth from the home infusion end-user segment in the infusion pumps market. Some infusion pumps that can be used at home include insulin pumps, PCA infusion pumps and elastomeric infusion pumps.
Growing Incidences of Pain, Cancer and Diabetes are fuelling the Demand for Infusion Pumps and Infusion Pump Accessories
Pain is one of the main reasons for hospital visits in over 50% of hospitalization cases globally. Over 33% of cancer survivors have chronic pain and need drugs administered through infusion pumps for rapid relief. Patients at home and outpatients can use patient controlled analgesic infusion pumps and ambulatory infusion pumps for rapid relief. Incorporation of advanced technology in infusion pumps helps in monitoring dosage more accurately and avoiding over-dosage errors. Similarly, diabetes incidences are increasing rapidly and as estimated by the NHS U.K., the number of cases has increased by ~60% over the past decade. These patients require small self-controlled infusion pumps such insulin infusion pumps for continuous monitoring purposes. Together, these factors are surging the demand for infusion pumps across all regions.
Infusion pumps market is favorable target market for acquisitions
Players dealing with hospital supplies are increasingly targeting the infusion pumps market to acquire leading companies. Infusion pump manufacturers facing a large number of product recalls are suitable acquisition targets. In February 2015, Pfizer acquired Hospira as the latter had been facing high infusion pump product recalls. Similarly, the infusion pump manufacturer, CareFusion Corporation was acquired by BD as the latter wanted to expand its market share in the surgical supplies segment.
Infusion Pump Market is fragmented in Nature with a Large Influx of Local Chinese and Indian Infusion Pump Manufacturers
The infusion pump market is fragmented with the prevalence of oligopolistic competition within categories. For example, Medtronic is clearly the infusion pump market leader, accounting for close to two-thirds of insulin infusion pump market revenue share. But the company does not possess a competitive advantage in other categories such as syringe infusion pumps and ambulatory infusion pumps. A large number of local players in emerging markets such as India and China will pose competition to established infusion pump manufacturers. These local players pose significant price competition to existing large infusion pumps manufacturers.
Note: For detailed analysis on all the key market factors, request a sample.
The FMI report provides detailed information about the growth parameters of the infusion pumps market with the help of a detailed assessment of the competitive environment in the Infusion pumps market. The market study provides comprehensive data on each stakeholder in the infusion pumps market, including B.Braun Melsungen AG., Becton, Dickinson and Company, Fresenius Kabi AG, Terumo Corporation, Medtronic Plc., Baxter International Inc., Smiths Medical, MOOG Inc., Johnson & Johnson Private Ltd. and Pfizer (Hospira) Inc. The report provides readers with all-encompassing data on each manufacturer’s revenue shares, winning strategies and latest information on mergers and acquisitions in the Infusion pumps market.
The market is gaining traction in terms of mergers and acquisitions and inorganic growth in terms of establishing wholly-owned local subsidiaries. For example, Pfizer acquired Hospira including all Infusion pumps and accessories business of the latter in September, 2015. BD acquired CareFusion Corporation in October, 2014 to emerge as one of the largest global leaders in medical technology, better positioned to partner with leading healthcare providers. BD also acquired the infusion pumps manufacturing company Caesarea Medical Electronics for US$ 250 Mn in 2017. This deal between these two infusion pump manufacturers is expected to bring out synergies in advanced technology development, which could lead to better designing of future infusion pumps.
Note: For full coverage of the competitive landscape, get in touch with our experts.
As per the U.S. FDA, “infusion pumps are defined as medical devices used to deliver fluids into a patient’s body in a controlled manner. There are many different types of infusion pumps, which are used for a variety of purposes and in a variety of environments. Infusion pumps may be capable of delivering fluids in large or small amounts, and may be used to deliver nutrients or medications – such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers”.
About the Report
The study of the infusion pumps market, recently published by FMI, provides comprehensive information about the most important market dynamics that are expected to prove instrumental in the growth of the infusion pumps market during 2018–2028. Market players can find the most accurate quantitative and qualitative information about growth parameters of the infusion pumps market in the report. The report encompasses detailed infusion pumps sales volumes and insights based on deep primaries with the leading manufacturers of infusion pumps.
The infusion pumps market report has been segmented in the most logical manner on key parameters, such as geographical region, product type, application type and end user, to analyze the segment-wise growth of the infusion pumps market. Based on geographical region, the infusion pumps market has been segmented into eight regions – North America, Latin America, Western Europe, Eastern Europe, China, Japan, Asia-Pacific Excluding China and Japan (APECJ), and the Middle East & Africa (MEA). The Infusion pumps market, on the basis of product type, has been segmented into syringe Infusion pumps, ambulatory infusion pumps, volumetric infusion pumps, implantable infusion pumps, insulin infusion pumps, enteral infusion pumps, PCA infusion pumps and infusion pump accessories. On the basis of application, the market has been segmented into chemotherapy/oncology, pediatrics/neonatology, analgesia gastroenterology, hematology and diabetes. By end user, the market has been segmented into hospitals, ambulatory surgical centers, home care, clinics and others.
Additional Questions Answered
Readers can find detailed information about the important factors that are augmenting and hampering the growth of the Infusion pumps market during the forecast period. Additionally, the report also contains valuable information that can provide infusion pumps market players with answers to critical questions, such as:
Which types of infusion pumps account for the maximum demand among customers adopting infusion therapy for patients?
Why are the sales of infusion pumps highest in North America? How are emerging markets fuelling market growth?
Which regulations in various regional segments are influencing the strategies of players in the infusion pumps market?
What is the hazard analysis of infusion pump usage?
The process of market research followed at FMI commences with extensive secondary research of the infusion pumps market. Analysts obtain industry-validated, historic and current data about the demand and sales of infusion pumps and accessories adopted across the globe. The comprehensive secondary research is followed by primary research, where detailed information about the Infusion pumps market is obtained in terms of value (US$ million) and volume in units. Based on the thorough secondary and primary research of growth parameters of the infusion pumps market, analysts come up with the most precise forecast on how the infusion pumps market will grow during the forecast period.
Note: Request methodology.
MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.Get A Free Custom Research Quote